INTERNATIONAL PATENT: NEWAMSTERDAM PHARMA B.V. FILES APPLICATION FOR "OBICETRAPIB FOR USE IN THE TREATMENT OF HEMOGLOBINOPATHIES"

GENEVA, July 14 -- NEWAMSTERDAM PHARMA B.V. (Gooimeer 2 351411 DC Naarden) filed a patent application (PCT/EP2024/080193) for "OBICETRAPIB FOR USE IN THE TREATMENT OF HEMOGLOBINOPATHIES" on Oct 25, 2024. With publication no. WO/2025/146262, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KASTELEIN, Johannes Jacob Pieter (Gooimeer 2 351411 DC Naarden), DITMARSCH, Marc (Gooimeer 2 351411 DC Naarden), NIESOR, Eric (13c Chemin de BonmontL260 Nyon, Vaud), CUI, Sheng (Gooimeer 2-351411 DC Naarden), ROTHELI, Andreas Rene (One Am...